Logo image of CDRE

CADRE HOLDINGS INC (CDRE) Stock Fundamental Analysis

NYSE:CDRE - New York Stock Exchange, Inc. - US12763L1052 - Common Stock - Currency: USD

36.03  +1.02 (+2.91%)

After market: 36.03 0 (0%)

Fundamental Rating

6

Overall CDRE gets a fundamental rating of 6 out of 10. We evaluated CDRE against 65 industry peers in the Aerospace & Defense industry. CDRE has an excellent profitability rating, but there are some minor concerns on its financial health. CDRE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CDRE had positive earnings in the past year.
CDRE had a positive operating cash flow in the past year.
CDRE had positive earnings in each of the past 5 years.
CDRE had a positive operating cash flow in each of the past 5 years.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

CDRE has a better Return On Assets (5.86%) than 73.85% of its industry peers.
Looking at the Return On Equity, with a value of 12.11%, CDRE is in the better half of the industry, outperforming 78.46% of the companies in the same industry.
CDRE's Return On Invested Capital of 8.93% is fine compared to the rest of the industry. CDRE outperforms 76.92% of its industry peers.
CDRE had an Average Return On Invested Capital over the past 3 years of 8.67%. This is in line with the industry average of 8.39%.
The last Return On Invested Capital (8.93%) for CDRE is above the 3 year average (8.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.86%
ROE 12.11%
ROIC 8.93%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 200 300 400

1.3 Margins

With a decent Profit Margin value of 6.87%, CDRE is doing good in the industry, outperforming 66.15% of the companies in the same industry.
In the last couple of years the Profit Margin of CDRE has grown nicely.
CDRE has a better Operating Margin (12.85%) than 81.54% of its industry peers.
In the last couple of years the Operating Margin of CDRE has grown nicely.
CDRE's Gross Margin of 41.44% is amongst the best of the industry. CDRE outperforms 84.62% of its industry peers.
In the last couple of years the Gross Margin of CDRE has grown nicely.
Industry RankSector Rank
OM 12.85%
PM (TTM) 6.87%
GM 41.44%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CDRE is destroying value.
CDRE has more shares outstanding than it did 1 year ago.
CDRE has more shares outstanding than it did 5 years ago.
CDRE has a worse debt/assets ratio than last year.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CDRE has an Altman-Z score of 4.20. This indicates that CDRE is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.20, CDRE is doing good in the industry, outperforming 61.54% of the companies in the same industry.
The Debt to FCF ratio of CDRE is 5.33, which is a neutral value as it means it would take CDRE, 5.33 years of fcf income to pay off all of its debts.
CDRE's Debt to FCF ratio of 5.33 is fine compared to the rest of the industry. CDRE outperforms 69.23% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that CDRE is somewhat dependend on debt financing.
CDRE's Debt to Equity ratio of 0.66 is on the low side compared to the rest of the industry. CDRE is outperformed by 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.33
Altman-Z 4.2
ROIC/WACC0.87
WACC10.26%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CDRE has a Current Ratio of 3.55. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.55, CDRE is doing good in the industry, outperforming 75.38% of the companies in the same industry.
CDRE has a Quick Ratio of 2.57. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CDRE (2.57) is better than 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 3.55
Quick Ratio 2.57
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The earnings per share for CDRE have decreased by -5.94% in the last year.
CDRE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.28% yearly.
Looking at the last year, CDRE shows a quite strong growth in Revenue. The Revenue has grown by 10.06% in the last year.
Measured over the past years, CDRE shows a small growth in Revenue. The Revenue has been growing by 6.17% on average per year.
EPS 1Y (TTM)-5.94%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%27.78%
Revenue 1Y (TTM)10.06%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%-5.62%

3.2 Future

Based on estimates for the next years, CDRE will show a very strong growth in Earnings Per Share. The EPS will grow by 20.01% on average per year.
Based on estimates for the next years, CDRE will show a small growth in Revenue. The Revenue will grow by 1.62% on average per year.
EPS Next Y41.1%
EPS Next 2Y27.38%
EPS Next 3Y20.01%
EPS Next 5YN/A
Revenue Next Year12.09%
Revenue Next 2Y10.64%
Revenue Next 3Y1.62%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 37.93, the valuation of CDRE can be described as expensive.
Based on the Price/Earnings ratio, CDRE is valued a bit cheaper than the industry average as 66.15% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CDRE to the average of the S&P500 Index (26.55), we can say CDRE is valued slightly more expensively.
CDRE is valuated rather expensively with a Price/Forward Earnings ratio of 24.67.
CDRE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CDRE is cheaper than 67.69% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.40, CDRE is valued at the same level.
Industry RankSector Rank
PE 37.93
Fwd PE 24.67
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

67.69% of the companies in the same industry are more expensive than CDRE, based on the Enterprise Value to EBITDA ratio.
CDRE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CDRE is cheaper than 78.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.39
EV/EBITDA 17.11
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

CDRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CDRE may justify a higher PE ratio.
A more expensive valuation may be justified as CDRE's earnings are expected to grow with 20.01% in the coming years.
PEG (NY)0.92
PEG (5Y)N/A
EPS Next 2Y27.38%
EPS Next 3Y20.01%

4

5. Dividend

5.1 Amount

CDRE has a Yearly Dividend Yield of 1.12%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.29, CDRE pays a better dividend. On top of this CDRE pays more dividend than 84.62% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, CDRE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.12%

5.2 History

CDRE has been paying a dividend for over 5 years, so it has already some track record.
CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

37.76% of the earnings are spent on dividend by CDRE. This is a low number and sustainable payout ratio.
DP37.76%
EPS Next 2Y27.38%
EPS Next 3Y20.01%
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

CADRE HOLDINGS INC

NYSE:CDRE (6/11/2025, 5:51:33 PM)

After market: 36.03 0 (0%)

36.03

+1.02 (+2.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners67.22%
Inst Owner Change3.63%
Ins Owners31.66%
Ins Owner Change0.15%
Market Cap1.46B
Analysts83.08
Price Target44.71 (24.09%)
Short Float %7.3%
Short Ratio6.66
Dividend
Industry RankSector Rank
Dividend Yield 1.12%
Yearly Dividend0.36
Dividend Growth(5Y)N/A
DP37.76%
Div Incr Years1
Div Non Decr Years3
Ex-Date05-02 2025-05-02 (0.095)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.05%
Min EPS beat(2)-31.8%
Max EPS beat(2)87.91%
EPS beat(4)3
Avg EPS beat(4)28.09%
Min EPS beat(4)-31.8%
Max EPS beat(4)87.91%
EPS beat(8)6
Avg EPS beat(8)27.15%
EPS beat(12)7
Avg EPS beat(12)11.71%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.72%
Min Revenue beat(2)0.97%
Max Revenue beat(2)4.48%
Revenue beat(4)2
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-15.05%
Max Revenue beat(4)4.48%
Revenue beat(8)6
Avg Revenue beat(8)0.54%
Revenue beat(12)9
Avg Revenue beat(12)1.09%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.88%
PT rev (3m)0.38%
EPS NQ rev (1m)-19.8%
EPS NQ rev (3m)-28.18%
EPS NY rev (1m)-0.51%
EPS NY rev (3m)-7.43%
Revenue NQ rev (1m)2.47%
Revenue NQ rev (3m)1.64%
Revenue NY rev (1m)1.59%
Revenue NY rev (3m)1.54%
Valuation
Industry RankSector Rank
PE 37.93
Fwd PE 24.67
P/S 2.62
P/FCF 35.39
P/OCF 31.15
P/B 4.61
P/tB 23.23
EV/EBITDA 17.11
EPS(TTM)0.95
EY2.64%
EPS(NY)1.46
Fwd EY4.05%
FCF(TTM)1.02
FCFY2.83%
OCF(TTM)1.16
OCFY3.21%
SpS13.77
BVpS7.81
TBVpS1.55
PEG (NY)0.92
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.86%
ROE 12.11%
ROCE 12.79%
ROIC 8.93%
ROICexc 11.71%
ROICexgc 28.76%
OM 12.85%
PM (TTM) 6.87%
GM 41.44%
FCFM 7.39%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
ROICexc(3y)11.24%
ROICexc(5y)14.1%
ROICexgc(3y)24.24%
ROICexgc(5y)30.41%
ROCE(3y)12.41%
ROCE(5y)17.14%
ROICexcg growth 3Y-11.18%
ROICexcg growth 5Y5.68%
ROICexc growth 3Y-14.82%
ROICexc growth 5Y2.49%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
F-Score6
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.33
Debt/EBITDA 2.37
Cap/Depr 34.49%
Cap/Sales 1.01%
Interest Coverage 4.65
Cash Conversion 53.27%
Profit Quality 107.66%
Current Ratio 3.55
Quick Ratio 2.57
Altman-Z 4.2
F-Score6
WACC10.26%
ROIC/WACC0.87
Cap/Depr(3y)35.32%
Cap/Depr(5y)31.71%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.04%
Profit Quality(3y)322.36%
Profit Quality(5y)273.24%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.94%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%27.78%
EPS Next Y41.1%
EPS Next 2Y27.38%
EPS Next 3Y20.01%
EPS Next 5YN/A
Revenue 1Y (TTM)10.06%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%-5.62%
Revenue Next Year12.09%
Revenue Next 2Y10.64%
Revenue Next 3Y1.62%
Revenue Next 5YN/A
EBIT growth 1Y15.12%
EBIT growth 3Y9.65%
EBIT growth 5Y15.18%
EBIT Next Year77.33%
EBIT Next 3Y30.01%
EBIT Next 5YN/A
FCF growth 1Y-9.79%
FCF growth 3Y-11.18%
FCF growth 5Y43.24%
OCF growth 1Y-6.33%
OCF growth 3Y-7.45%
OCF growth 5Y33.8%